There are 4 million Medicare beneficiaries who have not yet joined the new drug benefit. The more who sign up in 2007, the better for Big Pharma.
By Michael McCaughan
Seventy million prescriptions
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Cooperation between health technology assessment bodies across the EU will lead to a better joint clinical assessment process over time, but patients cannot afford a lengthy wait for improvements, speakers at a cell & gene therapy conference said.
European pharma trade associations EFPIA and EUCOPE outline their respective views on how the EU’s pharma legislation overhaul should tackle antimicrobial resistance, and why transferable exclusivity vouchers alone will not suffice as incentives.
The Trump Administration requested a dismissal or transfer of a lawsuit seeking to tighten the safety requirements for the abortion pill mifepristone on procedural grounds, which still leaves the administration's position on the case's merits unclear.
